연구 프로세스

477 동료 심사 연구의 그림

전체 Psyllium Husk Bifidobacterium lactis Fructooligosaccharides (FOS) Lactobacillus plantarum Peppermint Oil Pancreatic Enzymes (Pancrelipase) Curcumin Vitamin A Medium-Chain Triglycerides (MCT Oil) Galactooligosaccharides (GOS) Lactobacillus gasseri Aloe Vera (Inner Leaf Gel) Alpha-Galactosidase Vitamin D L-Glutamine Inulin Ginger Lactase Berberine Omega-3 Fatty Acids (EPA/DHA) Bovine Colostrum Zinc Bifidobacterium bifidum Butyrate (Sodium/Calcium Butyrate) Bacillus coagulans Saccharomyces boulardii Lactobacillus acidophilus N-Acetyl Cysteine (NAC) Bifidobacterium longum

All Types Chart Diagram Photograph Flowchart Forest Plot Micrograph Other

Figure 1. In the presence of an adequate amount of lactase, lactose is hydrolysed into galactose (Gal) and glucose (Glu), which are rapidly absorbed into the bloodstream, together with H2O molecules (modiﬁed from [5]).

Figure 5 Diagram

Schematic showing the enzymatic hydrolysis of lactose by lactase into galactose and glucose, which are then absorbed into the bloodstream. In lactase-sufficient individuals, this process occurs efficiently in the small intestinal brush border.

Lactose Maldigestion, Malabsorption, and Intolerance: A Comprehensive Review with a Focus on …

Figure 2. Some of the most important single nucleotide polymorphisms in the lactase gene (modiﬁed from [13]).

Figure 6 Diagram

Map of key single nucleotide polymorphisms (SNPs) in the lactase gene that regulate lactase persistence into adulthood. These genetic variants explain much of the population-level variation in the ability to digest lactose.

Lactose Maldigestion, Malabsorption, and Intolerance: A Comprehensive Review with a Focus on …

Figure 1 Chart

Microbial diversity comparison between healthy children and treatment-naive pediatric patients with newly diagnosed Crohn's disease. Alpha or beta diversity metrics reveal differences in the intestinal microbiome composition at disease onset.

Differences in the intestinal microbiome of healthy children and patients with newly …

Figure 2 Chart

Taxonomic composition analysis showing the relative abundance of major bacterial phyla or families in stool samples from pediatric Crohn's disease patients versus healthy controls.

Differences in the intestinal microbiome of healthy children and patients with newly …

Figure 3 Chart

Principal coordinate analysis or ordination plot illustrating the separation in gut microbial community structure between children with newly diagnosed Crohn's disease and age-matched healthy controls.

Differences in the intestinal microbiome of healthy children and patients with newly …

Figure 4 Chart

Differential abundance analysis identifying specific bacterial taxa that are significantly enriched or depleted in the intestinal microbiome of treatment-naive pediatric Crohn's disease patients.

Differences in the intestinal microbiome of healthy children and patients with newly …

Figure 5 Chart

Correlation analysis or network diagram showing relationships between specific gut bacterial taxa and clinical parameters in pediatric Crohn's disease at the time of diagnosis.

Differences in the intestinal microbiome of healthy children and patients with newly …

Figure 1. The curcumin activity in mucosal.

Figure 1 Diagram

Curcumin's activity in the intestinal mucosa is illustrated, highlighting its anti-inflammatory mechanisms in the gastrointestinal tract. The diagram depicts how curcumin may modulate immune signaling pathways relevant to inflammatory bowel disease, including Crohn's disease and ulcerative colitis.

Curcumin and inflammatory bowel disease: potential and limits of innovative treatments.

Figure 2 Diagram

Molecular pathways and cellular targets of curcumin in inflammatory bowel disease are presented. The anti-oxidant and anti-inflammatory properties of curcumin are linked to its potential therapeutic applications in managing chronic gastrointestinal inflammation.

Curcumin and inflammatory bowel disease: potential and limits of innovative treatments.

Figure 1. Bone mass throughout the life span. Bone accumulates rapidly in childhood and grows at maximal rates during puberty. Peak bone mass is reached by age 30, and then slowly decreases. Females typically accumulate less bone mass than males and rapid

Figure 5 Chart

Bone mass changes throughout the human lifespan are charted, showing rapid accumulation during childhood, peak bone mass around age 30, and subsequent gradual decline. Females typically experience accelerated bone loss after menopause, underscoring the importance of adequate calcium intake in earlier decades.

Lactose Intolerance and Bone Health: The Challenge of Ensuring Adequate Calcium Intake.

Figure 1 Flowchart

A PRISMA-style flowchart details the study selection protocol for this systematic review of zinc supplementation in diarrhea, showing the screening and inclusion criteria applied to identify eligible trials.

Therapeutic value of zinc supplementation in acute and persistent diarrhea: a systematic …

Figure 2 Chart

Subgroup comparisons of zinc dosage and formulation effects on diarrhea outcomes are depicted, highlighting dose-response relationships observed across studies.

Therapeutic value of zinc supplementation in acute and persistent diarrhea: a systematic …

Figure 3 Chart

Pooled results from clinical trials assessing zinc's therapeutic value in reducing diarrhea duration and severity are presented, with subgroup analyses by diarrhea type.

Therapeutic value of zinc supplementation in acute and persistent diarrhea: a systematic …

Figure 4 Chart

Effect size estimates for zinc supplementation across different age groups and diarrhea classifications are compared, indicating varying degrees of clinical benefit.

Therapeutic value of zinc supplementation in acute and persistent diarrhea: a systematic …

Figure 5 Chart

Alpha diversity indices of fecal microbiota are plotted for treated versus placebo groups, indicating whether probiotic supplementation altered overall bacterial community richness.